Consensus statement on the use of systemic therapies in pancreatic ductal adenocarcinoma in Asia

Systemic therapies, primarily cytotoxic chemotherapies, are the mainstay treatment option for pancreatic ductal adenocarcinoma (PDAC) alongside surgery. Several guidelines exist for managing PDAC within Asia, but recommendations for systemic therapies can differ significantly. Consequently, geograph...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	D.-Y. Oh, B. Shen, S. Satoi, J. Zhou, K.-P. Kim, S.P. Choo, S.M. Woo, S.L. Chan, L. Shen, M. Ikeda
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Elsevier 2025-06-01
סדרה:	ESMO Gastrointestinal Oncology
נושאים:	pancreatic cancer pancreatic ductal adenocarcinoma systemic therapies expert consensus Delphi method Asia
גישה מקוונת:	http://www.sciencedirect.com/science/article/pii/S2949819825000275
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!